Soyabean protein hydrolysate prevents the development of hypertension in spontaneously hypertensive rats

Hsin Yi Yang, Suh Ching Yang, Jiun Rong Chen, Ya Hui Tzeng, Bor Cheng Han

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The aim of the present study was to investigate the anti-hypertensive and angiotensin-converting enzyme (ACE) inhibition effects of soyabean protein hydrolysate in spontaneously hypertensive rats (SHR). Soyabean protein hydrolysate was prepared by peptic hydrolysis and was added into the feed of SHR (0 % for the S0 group, 0.5 % for the S1 group, and 1% for the S2 group) for 12 weeks. Systolic blood pressure and mean blood pressure of the S1 (164.3 (SEM 4.7); 128.0 (SEM 5.0) mmHg) and S2 (156.8 (SEM 1.6); 120.8 (SEM 3.4) mmHg) groups were significantly lower than those of the S0 group (199.4 (SEM 5.2); 158.3 (SEM 7.0) mmHg) at the end of the study. In the analysis of ACE activity, plasma and heart ACE activities of the S1 and S2 groups were significantly lower than those of the S0 group, and there were no significant differences in aorta, kidney, and lung ACE activities among all SHR. Soyabean protein hydrolysate had no significant effect on plasma lipids, electrolytes, or on left ventricular wall or aorta wall thickness. The results suggest that the long-term administration of soyabean protein hydrolysate might retard the development of hypertension in SHR by its inhibitory effect on ACE in vivo.

Original languageEnglish
Pages (from-to)507-512
Number of pages6
JournalBritish Journal of Nutrition
Volume92
Issue number3
DOIs
Publication statusPublished - Sep 2004

Fingerprint

Protein Hydrolysates
Peptidyl-Dipeptidase A
Inbred SHR Rats
Hypertension
Blood Pressure
Aorta
Antihypertensive Agents
Electrolytes
Digestion
Hydrolysis
Kidney
Lipids
Lung

Keywords

  • Angiotensin-converting enzyme
  • Blood pressure
  • Hypertension
  • Soyabean protein
  • Spontaneously hypertensive rats

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Soyabean protein hydrolysate prevents the development of hypertension in spontaneously hypertensive rats. / Yang, Hsin Yi; Yang, Suh Ching; Chen, Jiun Rong; Tzeng, Ya Hui; Han, Bor Cheng.

In: British Journal of Nutrition, Vol. 92, No. 3, 09.2004, p. 507-512.

Research output: Contribution to journalArticle

@article{2a6031c432ad42e48235830e8e9bb5d5,
title = "Soyabean protein hydrolysate prevents the development of hypertension in spontaneously hypertensive rats",
abstract = "The aim of the present study was to investigate the anti-hypertensive and angiotensin-converting enzyme (ACE) inhibition effects of soyabean protein hydrolysate in spontaneously hypertensive rats (SHR). Soyabean protein hydrolysate was prepared by peptic hydrolysis and was added into the feed of SHR (0 {\%} for the S0 group, 0.5 {\%} for the S1 group, and 1{\%} for the S2 group) for 12 weeks. Systolic blood pressure and mean blood pressure of the S1 (164.3 (SEM 4.7); 128.0 (SEM 5.0) mmHg) and S2 (156.8 (SEM 1.6); 120.8 (SEM 3.4) mmHg) groups were significantly lower than those of the S0 group (199.4 (SEM 5.2); 158.3 (SEM 7.0) mmHg) at the end of the study. In the analysis of ACE activity, plasma and heart ACE activities of the S1 and S2 groups were significantly lower than those of the S0 group, and there were no significant differences in aorta, kidney, and lung ACE activities among all SHR. Soyabean protein hydrolysate had no significant effect on plasma lipids, electrolytes, or on left ventricular wall or aorta wall thickness. The results suggest that the long-term administration of soyabean protein hydrolysate might retard the development of hypertension in SHR by its inhibitory effect on ACE in vivo.",
keywords = "Angiotensin-converting enzyme, Blood pressure, Hypertension, Soyabean protein, Spontaneously hypertensive rats, Angiotensin-converting enzyme, Blood pressure, Hypertension",
author = "Yang, {Hsin Yi} and Yang, {Suh Ching} and Chen, {Jiun Rong} and Tzeng, {Ya Hui} and Han, {Bor Cheng}",
year = "2004",
month = "9",
doi = "10.1079/BJN20041218",
language = "English",
volume = "92",
pages = "507--512",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",
number = "3",

}

TY - JOUR

T1 - Soyabean protein hydrolysate prevents the development of hypertension in spontaneously hypertensive rats

AU - Yang, Hsin Yi

AU - Yang, Suh Ching

AU - Chen, Jiun Rong

AU - Tzeng, Ya Hui

AU - Han, Bor Cheng

PY - 2004/9

Y1 - 2004/9

N2 - The aim of the present study was to investigate the anti-hypertensive and angiotensin-converting enzyme (ACE) inhibition effects of soyabean protein hydrolysate in spontaneously hypertensive rats (SHR). Soyabean protein hydrolysate was prepared by peptic hydrolysis and was added into the feed of SHR (0 % for the S0 group, 0.5 % for the S1 group, and 1% for the S2 group) for 12 weeks. Systolic blood pressure and mean blood pressure of the S1 (164.3 (SEM 4.7); 128.0 (SEM 5.0) mmHg) and S2 (156.8 (SEM 1.6); 120.8 (SEM 3.4) mmHg) groups were significantly lower than those of the S0 group (199.4 (SEM 5.2); 158.3 (SEM 7.0) mmHg) at the end of the study. In the analysis of ACE activity, plasma and heart ACE activities of the S1 and S2 groups were significantly lower than those of the S0 group, and there were no significant differences in aorta, kidney, and lung ACE activities among all SHR. Soyabean protein hydrolysate had no significant effect on plasma lipids, electrolytes, or on left ventricular wall or aorta wall thickness. The results suggest that the long-term administration of soyabean protein hydrolysate might retard the development of hypertension in SHR by its inhibitory effect on ACE in vivo.

AB - The aim of the present study was to investigate the anti-hypertensive and angiotensin-converting enzyme (ACE) inhibition effects of soyabean protein hydrolysate in spontaneously hypertensive rats (SHR). Soyabean protein hydrolysate was prepared by peptic hydrolysis and was added into the feed of SHR (0 % for the S0 group, 0.5 % for the S1 group, and 1% for the S2 group) for 12 weeks. Systolic blood pressure and mean blood pressure of the S1 (164.3 (SEM 4.7); 128.0 (SEM 5.0) mmHg) and S2 (156.8 (SEM 1.6); 120.8 (SEM 3.4) mmHg) groups were significantly lower than those of the S0 group (199.4 (SEM 5.2); 158.3 (SEM 7.0) mmHg) at the end of the study. In the analysis of ACE activity, plasma and heart ACE activities of the S1 and S2 groups were significantly lower than those of the S0 group, and there were no significant differences in aorta, kidney, and lung ACE activities among all SHR. Soyabean protein hydrolysate had no significant effect on plasma lipids, electrolytes, or on left ventricular wall or aorta wall thickness. The results suggest that the long-term administration of soyabean protein hydrolysate might retard the development of hypertension in SHR by its inhibitory effect on ACE in vivo.

KW - Angiotensin-converting enzyme

KW - Blood pressure

KW - Hypertension

KW - Soyabean protein

KW - Spontaneously hypertensive rats

KW - Angiotensin-converting enzyme

KW - Blood pressure

KW - Hypertension

UR - http://www.scopus.com/inward/record.url?scp=6944251245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6944251245&partnerID=8YFLogxK

U2 - 10.1079/BJN20041218

DO - 10.1079/BJN20041218

M3 - Article

C2 - 15469655

AN - SCOPUS:6944251245

VL - 92

SP - 507

EP - 512

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - 3

ER -